This document discusses dizziness and vertigo from an otoneurological perspective. It begins by outlining key questions to ask patients regarding the nature and characteristics of their dizziness. It then describes potential otologic and neurological symptoms. Specific balance and vestibular tests are discussed, including nystagmus patterns, bedside tests like head thrust and positional maneuvers for BPPV. Common causes of vertigo like BPPV, vestibular neuritis, Meniere's disease, migraines, and strokes are explained. Appropriate use of anti-vertigo medications is emphasized.
Ephaptic transmission of impulses between neighbouring neurons (i.e. coupling of adjacent nerve fibres due to local exchange of ions or local electric fields) leading to excessive or abnormal firing.
Ephaptic transmission of impulses between neighbouring neurons (i.e. coupling of adjacent nerve fibres due to local exchange of ions or local electric fields) leading to excessive or abnormal firing.
Vestibular function tests are essential tests in otorhinolaryngology examination, especially examination of ear.
This presentation explains about all the important vestibular function tests.
Videonystagmography is also known as VNG, is a most advanced diagnostic test for a balance disorder. Individuals who feel dizzy and face difficulty in maintaining their balance and equilibrium should undergo the videonystagmography diagnostic test.
I was asked to give a brief update at the Saunder's Symposium for the Department of Otolaryngology at The Ohio State University in 2012. This was a great honor. The videos have been removed due to size of the file.
Vestibular function tests are essential tests in otorhinolaryngology examination, especially examination of ear.
This presentation explains about all the important vestibular function tests.
Videonystagmography is also known as VNG, is a most advanced diagnostic test for a balance disorder. Individuals who feel dizzy and face difficulty in maintaining their balance and equilibrium should undergo the videonystagmography diagnostic test.
I was asked to give a brief update at the Saunder's Symposium for the Department of Otolaryngology at The Ohio State University in 2012. This was a great honor. The videos have been removed due to size of the file.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
14. Evaluation of the
DIZZY PATIENT
What type of dizziness is it?
How long does it last? Continuous or episodic
Spontaneous or positional
Duration of vertigo if episodic
Are there otologic symptoms?
Are there focal neurological symptoms?
15. Otologic Symptoms in the
Dizzy Patient
Hearing Loss: progressive, sudden
SNHL,congenital, fluctuating
Tinnitus: continuous or episodic
Aural fullness
Ear pain, or chronic drainage
History of ear surgeries/infection
16. Focal Neurological Symptoms
Vertigo if secondary to cerebrovascular insufficiency is
indicative of posterior circulatory problems
Visual loss
Loss of consciousness
Numbness especially if on one side
Weakness especially if on one side
Incoordination as if drunk, esp if in spells
Difficulty swallowing
Slurring of the speech
17. Evaluation of the
Dizzy Patient
Family History:
Hearing Loss
Vertigo Spells
Headaches or visual auras
Gait ataxia or imbalance
18. Nystagmus: Features of Peripheral
Spontaneous nystagmus from imbalance of signals
from the right and left vestibular periphery
The resulting nystagmus is a combined torsional,
horizontal.
Alexander’s law: Increased frequency and amplitude of
nystagmus with gaze in direction of fast component,
reverse effect with gaze opposite to the fast
component.
Inhibited by fixation
19. Features of Central Nystagmus
Prominent with and without fixation
Can be purely vertical (always central), horizontal, or
torsional, of have some combination
The rule is if the nystagmus is vertical (upbeat or
downbeat), it is central i.e. not coming from the inner
ear
Cerebellar: spontaneous downbeat with vertical
amplitude increasing with horizontal gaze deviation
or brought out when placed in supine position
20.
21. Bedside Tests of Vestibular Function:
Dynamic Visual Acuity
Oscillopsia : perception of environment jumping up and
down when walking.
Ask the patient: “Can you read the print on the cans while
walking down the grocery store aisle?”
May be a sign of bilateral loss of VOR function
Horizontal passive rotation at 2 Hz. Normal is loss of 1 line of
Snellen acuity card, bilateral vestibular loss will lose 5
lines.
22. Bedside Tests of
Horizontal VOR: Head Thrust Test
Rapid, high-acceleration head thrust with patient fixating on
examiner’s nose
Corrective saccade (catch-up saccade) when head is rotated
toward the affected vestibular periphery is positive
Positive in vestibular neuritis, gentamicin ototoxicity
(bilateral), idiopathic and autoimmune vestibulopathy
May be normal to have slight VOR hypometria bilaterally in
older patients
24. Ataxia Syndromes
• Patient may present with unsteadiness, limb incoordination,
dysarthria.
• On examination, there may be dysmetria on FTN testing
• On ENG testing, hypermetric saccades, abnormalities of OKN, or
of smoooth pursuit.
• MRI : atrophy of the cerebellar vermis and / or hemispheres
25. Spinocerebellar Ataxia
Familial SCA 6
Accounts for 5-15% of SCA autosomal dominant in U.S. (higher
% in Japan)
Onset of symptoms usually 3rd to 6th decade
Usually complain of episodic vertigo and oscillopsia,
» especially immediately after lying supine from the sitting
position, or quick turn of the head
Chromosome 19p VGCC (CAG repeat)
» highly expressed in the cerebellum
Down-beat nystagmus in supine position
–
26. Benign Paroxysmal Positional Vertigo
Otolithic calcium carbonate crystals become loose, and fall into the
posterior semicircular canal
Common with head trauma, older age, inner ear disease
One of the most common cause of vertigo seen in neurotology clinics,
estimated at 20-30% of patients
27. Benign Paroxysmal Positional Vertigo
Typical complaint: spells of vertigo when turning over in bed, “top shelf
vertigo”
Examine the patient for nystagmus and vertigo in the Dix-Hallpike
position : head-hanging R and L
Vertigo lasts shorter than 1 minute
Geotropic, torsional nystagmus
with upbeat component
Brought on only by positional changes
Latency of few seconds up to 45 sec
Fatigues with repeated testing
29. Epidemiology of BPPV
• Lifetime prevalence of 3.2% in females and 1.6% in males
• Of 100 unselected elderly patients, a prevalence of 9% was
reported
• Median duration of two weeks
• Female preponderance likely reflects the association of migraine
with BPPV
• Association of BPPV with hypertension and hyperlipidemia
• Vascular damage to the inner ear facilitates detachment of the
otoconia
• Von Brevern et al., 2006
30. Benign Paroxysmal Positional Vertigo
Can be presentation of acoustic / inner ear disease: screening
audiogram is preferred
Etiology of BPPV in 240 patients (Baloh et al., 1987)
Idiopathic in 49%
Traumatic in 18%
Viral Labyrinthitis in 15%
VBI in 5%
Meniere’s in 2%
Surgery in 4%
Ototoxicity in 2%
Idiopathic young patients: 3x incidence of migraine vs. in those with
BPPV with known cause (e.g. head trauma) Ishiyama et al., 2000
31. Positional and Spontaneous
Vertigo:
Multiple Sclerosis
Vertigo is the initial symptom of MS in 5%, and presents in 50%
of MS patients at some time in the course.
25% of patients with MS have caloric paresis
80% have eye movement abnormalities
Oftentimes abnormalities on ABR and occasionally retrocochlear
hearing loss from involvement at the root entry zone near pons
32. Positional and Spontaneous Vertigo:
Multiple Sclerosis
Demyelinating disease of unknown etiology
Onset usually in 3rd and 4th decade of life
Common associated signs and symptoms: INO (internuclear
ophthalmoplegia), optic neuritis, Llermitte’s sign, vibratory
loss, spasticity, sensitivity to temperature
MRI with FLAIR: plaques
33. Meniere’s Disease
Symptoms: Fluctuating hearing loss, tinnitus, ear fullness, and
vertigo. May have initially only hearing loss or only vertigo
spells.
Possibly sudden falls (Tumarkin crisis)
Hearing loss, tinnitus, and aural fullness increase during the
vertigo attack
Typically lasts 20 minutes or more in duration
34. Meniere’s Disease
On temporal bone histopathology, there is a distension of the
entire endolymphatic system
Audiogram: often low-frequency sensorineural hearing loss
that increases during attacks.
ENG: Vestibular paresis or directional preponderance to
bithermal caloric stimulation
35. Meniere’s Disease:
Tumarkin falls
In about 7-10% of Meniere’s disease, there are associated
sudden falls “drop attacks”
No warning, sudden, violent fall without loss of consciousness
Subjective sensation of being pushed by an external force
Recently noted to be associated with migraine
(Ishiyama et al., 2003)
Surgical ablation is curative of these dangerous and frightening
drop attacks
36. Meniere’s Disease Variant:
Delayed Endolymphatic Hydrops
Delayed hydrops develops in an ear that has h/o profound
SNHL years before (up to 70 years before)
Many years later: recurrent spells of vertigo of 20 minutes
duration or longer
Often without accompanying otologic symptoms of aural
fullness, increased tinnitus and hearing fluctuation
Can also have Tumarkin falls
37. Migraine-associated Vertigo
Vestibular Meniere’s, migraine-associated vestibulopathy, benign
paroxysmal vertigo
25% of patients with migraine have vertigo spells
Duration of the vertigo varies:
31% few min-2 hr
49% > 24 hrs
7% seconds
25% of patients with migraine have caloric paresis
Isolated vertigo without headache are termed migraine equivalent
38. Migraine-associated Vertigo
Migraine is an inherited, likely metabolic syndrome with
multiple causes, likely autosomal dominant with variable
penetrance
Always ask about the family history
Ask about h/o motion sickness (50%)
Ask about h/o altitude sickness
Ask about sensitivity to visual stimuli (bright lights/ patterns,
panoramic theater, computer work)
39. Migraine-associated Vertigo
Ask about h/o recurrent abdominal pains or cyclical vomiting
as child, which is usually migraine equivalent
Ask women specifically regarding menses: some will call
migraine headaches “PMS”
Migraine-associated vertigo often has a catamenial
component, or worsened by OCP in women
40. International Headache Society
Criteria for Migraine Headaches
• At least 5 attacks fulfilling B-D
• B. Headache lasting 4-72 hrs
• C. At least 2 of: unilateral, pulsating, moderate or severe,
aggravation by physical activity
• D. At least one of N/V, photophobia and phonophobia
• Other causes ruled out
41. Variants of Migraine
Migraine visual aura: Visual aura may occur isolated without
headache: fortification spectra, scotoma, stars, patterns of
colored lights lasting usually 15-20 minutes
Retinal migraine: retinal artery vasospasm which can cause
monocular blindness: prophylaxis with verapamil
Benign paroxysmal vertigo of childhood: recurrent spells of
vertigo in child is usually migraine, may or may not have H/A
42. Association between Migraine
and Vestibulopathy
Tumarkin falls may be associated with migraine
Out of 55 patients with Tumarkin falls, 6 had >1yr h/o normal
hearing
5 out of 6 had h/o migraine
Tumarkin falls are known to localize to the vestibular
periphery since surgery is curative
Ishiyama et al., 2003
43. Vestibular Neuritis
Subacute onset of vertigo, often with nausea and vomiting
Vertigo lasts a few days, and crescendos in few hours, and
decreases in severity with time
Suspicion for viral cause but evidence for ischemic causes
Temporal bone histopathology: Scarpa’s ganglion neuronal loss
44. Vertebrobasilar insufficiency
20% of all strokes are in the vertebrobasilar distribution
Usually from atherosclerotic disease, but 1/5 of infarcts may be
cardioembolic
Common cause of episodic, spontaneus vertigo of abrupt onset
in older patients
Grad and Baloh (1989): 62% had isolated vertigo without
associated neurological deficits, and 19% had isolated
vertigo as first TIA
Several minutes (3-4 min) duration is always suspicious for TIA
45. Vertebrobasilar insufficiency
Visual (diplopia/ illusions, field defects in 69%
Drop attacks in 33%
Imbalance/ incoordination in 21%
Extremity weakness in 21%
Confusion in 17%
Headache in 14%
Hearing loss in 14%
Loss of consciousness in 9.5%
Extremity numbness in 9.5%
Dysarthira in 9.5%
Tinnitus in 9.5%
Perioral numbness in 5%
46.
47. Stroke syndrome with vertigo:
Wallenberg syndrome
Dorsolateral medullary syndrome
PICA (posterior inferior cerebellar artery)
Vertebral atherosclerotic disease
(artery to artery emboli) prior to takeoff
Consider vertebral dissection
Look for h/o neck trauma or manipulation
48. Wallenberg symptoms
Right Dorsolateral medullary stroke
Nystagmus and vertigo (vestibular nuclei)
Difficulty swallowing, hoarse voice, absent gag on R (nucleus
ambiguus)
Difficulty limb coordination on the right FTN, HTS (right
cerebellum)
On walking, veers and falls to the right
Pain and temperature loss on right face and left leg, trunk, arm
(spinothalamic)
Right Horner’s: ptosis, miosis, anhydrosis (reticulospinal fibers
in lateral medulla)
49. Stroke syndrome with vertigo:
Anterior inferior cerebellar artery
Vertigo
Tinnitus, hearing loss secondary to infarct
of cochlea/nerve or cochlear nucleus
Ataxia
Facial paralysis and numbness
Ispilateral Horner’s
50. Stroke syndrome with vertigo:
Labyrinthine infarction
Occlusion of the internal auditory artery
Sudden, profound hearing loss
Acute onset of spontaneous vertigo lasting days
Consider the diagnosis in older patients with h/o TIA,
stroke, or atherosclerotic vascular disease
51. Cerebellar Hemorrhage
Etiology is hypertensive vascular disease in 2/3 of patients
Acute onset of vertigo, nausea, and vomiting and severe
headache, inability to stand
Spontaneous or gaze evoked nystagmus, dysmetria, truncal
ataxia
Often requires prompt evaluation and surgical decompression
to prevent progression to coma or even death from
herniation